A hands-on neurological examination adds < 5 minutes to the average neurologist consultation, according to results from a study that reviewed more than 4000 patient visits. […]

LOS ANGELES — The median cost of brand-name anti-seizure medications (ASMs) in the United States almost doubled from 2013 to 2023, whereas generic ASM prices declined […]

Deep brain stimulation (DBS) of the lateral hypothalamus (LH) improves walking and promotes recovery in patients with spinal cord injury (SCI), new research showed. This intervention […]

Decreasing the number of migraine attacks and resolving each attack quickly when it occurs are more important than ever, according to an expert; the reason is […]

Los Angeles — Only about 27% of patients newly diagnosed with focal epilepsy are seizure-free on initial anti-seizure medications (ASMs), new research suggested. This is sobering […]

LOS ANGELES — The majority of women with epilepsy are inadequately educated about the potential risks associated with anti-seizure medications (ASMs), which include teratogenicity and a […]

LOS ANGELES — Artificial intelligence (AI) analysis of caregiver-recorded videos has the potential to diagnose infantile epileptic spasm syndrome, according to a new study. Infants with […]

An estimated 14 million older adults in the United States live with mild cognitive impairment (MCI). While many will never progress to dementia — experiencing stable […]